港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

撥康視雲-B

1.870

-0.100-5.08%

成交量：60.30萬

成交額：111.90萬

市值：15.90億

市盈率：-8.97

高：1.940

開：1.930

低：1.820

收：1.970

52周最高：9.740

52周最低：1.820

股本：8.50億

香港流通股本：8.50億

量比：1.30

換手率：0.07%

股息：- -

股息率：- -

每股收益(LYR):-0.209

淨資產收益率：--

總資產收益率：-44.38%

市淨率：-0.61

市盈率(LYR):-8.97

市銷率: 19.81

資料載入中...

總覽公司新聞資訊公告

港股異動 | 撥康視雲-B(02592)跌超6%創新低宣佈撤回CBT-009新藥臨床試驗申請

撥康視雲-B(02592)：撤回CBT-009新藥臨床試驗申請重新評估臨床開發策略

撥康視雲-B(02592)股東將股票存入建設亞洲存倉市值1.94億港元

每日沽空追蹤 | 撥康視雲-B 03月12日沽空量成交6500股，沽空比例為1.84%

撥康視雲-B盤中異動下午盤大幅下挫5.26%報2.160港元

撥康視雲-B盤中異動大幅下跌6.88%報2.030港元

撥康視雲-B盤中異動早盤大幅跳水5.88%

每日沽空追蹤 | 撥康視雲-B 03月02日沽空量成交2.1萬股，沽空比例為2.48%

Cloudbreak Pharma（02592）2026年2月無新增發行或股份變動

撥康視雲-B盤中異動股價大跌5.83%

每日沽空追蹤 | 撥康視雲-B 02月27日沽空量成交1000股，沽空比例為0.38%

每日沽空追蹤 | 撥康視雲-B 02月26日沽空量成交2.05萬股，沽空比例為7.36%

每日沽空追蹤 | 撥康視雲-B 02月24日沽空量成交1.65萬股，沽空比例為7.45%

每日沽空追蹤 | 撥康視雲-B 02月16日沽空量成交1.45萬股，沽空比例為15.26%

撥康視雲-B(02592)：CBT-199新藥臨床試驗申請已生效，臨床試驗被認定為可安全推進

每日沽空追蹤 | 撥康視雲-B 02月12日沽空量成交1.35萬股，沽空比例為2.61%

撥康視雲-B盤中異動臨近收盤大幅下挫5.04%報2.260港元

每日沽空追蹤 | 撥康視雲-B 02月10日沽空量成交2.1萬股，沽空比例為11.05%

每日沽空追蹤 | 撥康視雲-B 02月09日沽空量成交9500股，沽空比例為1.05%

每日沽空追蹤 | 撥康視雲-B 02月06日沽空量成交2.9萬股，沽空比例為3.31%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02592/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"撥康視雲-B","latestPrice":1.87,"timestamp":1773994128005,"preClose":1.97,"halted":0,"volume":603000,"delay":0,"changeRate":-0.050761421319796884,"floatShares":850000000,"shares":850000000,"eps":-0.208525,"marketStatus":"已收盤","change":-0.1,"latestTime":"03-20 16:08:48","open":1.93,"high":1.94,"low":1.82,"amount":1118970,"amplitude":0.060914,"askPrice":1.87,"askSize":4500,"bidPrice":1.85,"bidSize":7000,"shortable":3,"etf":0,"ttmEps":-0.386,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":1.97,"openAndCloseTimeList":[[1773970200000,1773979200000],[1773982800000,1773993600000]],"volumeRatio":1.29817,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":850000000,"roa":"-44.38%","roe":"--","lyrEps":-0.208525,"volumeRatio":1.29817,"shares":850000000,"dividePrice":0,"high":1.94,"amplitude":0.060914,"preClose":1.97,"low":1.82,"week52Low":1.82,"pbRate":"-0.61","psRate":"19.81","week52High":9.74,"institutionHeld":0,"latestPrice":1.87,"committee":0.217391,"eps":-0.208525,"divideRate":0,"volume":603000,"delay":0,"ttmEps":-0.386,"open":1.93,"prevYearClose":5.2,"prevWeekClose":2.05,"prevMonthClose":2.23,"prevQuarterClose":5.2,"fiveDayClose":2.05,"twentyDayClose":2.23,"sixtyDayClose":5.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2026-03-19","current":-4.84456,"percent":1,"low":-24.505522,"twenty":-12.646004,"median":-6.640729,"eighty":-5.717572,"high":-5.043522,"avg":-9.350243,"sd":4.516023,"marketCap":1652618961},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586},{"date":"2025-08-29","current":-5.503941,"twenty":-6.295753,"median":-5.870846,"eighty":-5.538055,"marketCap":4253186871},{"date":"2025-09-05","current":-5.413205,"twenty":-6.239682,"median":-5.742284,"eighty":-5.49926,"marketCap":4186075441},{"date":"2025-09-12","current":-12.640894,"twenty":-6.350655,"median":-5.870846,"eighty":-5.508123,"marketCap":4118964011},{"date":"2025-09-19","current":-12.711577,"twenty":-6.612702,"median":-6.004685,"eighty":-5.525012,"marketCap":4135741868},{"date":"2025-09-26","current":-11.804503,"twenty":-12.358821,"median":-6.058573,"eighty":-5.527436,"marketCap":3842129362},{"date":"2025-10-03","current":-6.439136,"twenty":-12.191113,"median":-6.134046,"eighty":-5.53457,"marketCap":2096453591},{"date":"2025-10-10","current":-5.988337,"twenty":-11.881825,"median":-6.134089,"eighty":-5.548508,"marketCap":1949083838},{"date":"2025-10-17","current":-12.3346,"twenty":-12.21981,"median":-6.187936,"eighty":-5.561014,"marketCap":4009907937},{"date":"2025-10-24","current":-11.844495,"twenty":-12.25273,"median":-6.279578,"eighty":-5.580054,"marketCap":3850518291},{"date":"2025-10-31","current":-12.15705,"twenty":-12.335851,"median":-6.333467,"eighty":-5.585568,"marketCap":3951185436},{"date":"2025-11-07","current":-11.838569,"twenty":-12.273198,"median":-6.424535,"eighty":-5.601607,"marketCap":3850518291},{"date":"2025-11-14","current":-11.510378,"twenty":-12.207573,"median":-6.465107,"eighty":-5.621104,"marketCap":3741462218},{"date":"2025-11-21","current":-12.23865,"twenty":-12.234818,"median":-6.500592,"eighty":-5.630174,"marketCap":3984741151},{"date":"2025-11-28","current":-21.343443,"twenty":-12.412307,"median":-6.613869,"eighty":-5.677994,"marketCap":6946032996},{"date":"2025-12-05","current":-20.614529,"twenty":-12.626633,"median":-6.790202,"eighty":-5.718633,"marketCap":6711142992},{"date":"2025-12-12","current":-17.961539,"twenty":-12.716498,"median":-11.142834,"eighty":-5.735493,"marketCap":5847083331},{"date":"2025-12-19","current":-14.819321,"twenty":-12.837409,"median":-11.27102,"eighty":-5.75741,"marketCap":4823634025},{"date":"2025-12-24","current":-14.055026,"twenty":-12.984934,"median":-11.600706,"eighty":-5.767869,"marketCap":4571966163},{"date":"2026-01-02","current":-11.620216,"twenty":-12.995771,"median":-11.729724,"eighty":-5.769371,"marketCap":3783406861},{"date":"2026-01-09","current":-7.540769,"twenty":-12.961935,"median":-11.510378,"eighty":-5.972321,"marketCap":2457956120},{"date":"2026-01-16","current":-8.049692,"twenty":-12.941587,"median":-11.169175,"eighty":-5.988337,"marketCap":2625734695},{"date":"2026-01-23","current":-6.609576,"twenty":-12.863288,"median":-10.620058,"eighty":-5.996682,"marketCap":2155954686},{"date":"2026-01-30","current":-6.294491,"twenty":-12.820156,"median":-9.452561,"eighty":-6.004685,"marketCap":2055287541},{"date":"2026-02-06","current":-5.800172,"twenty":-12.797534,"median":-8.075865,"eighty":-6.004685,"marketCap":1895897895},{"date":"2026-02-13","current":-5.772062,"twenty":-12.788929,"median":-7.957902,"eighty":-5.976779,"marketCap":1887508966},{"date":"2026-02-20","current":-5.722622,"twenty":-12.762909,"median":-7.89408,"eighty":-5.899654,"marketCap":1870731109},{"date":"2026-02-27","current":-5.716309,"twenty":-12.718958,"median":-7.540769,"eighty":-5.819712,"marketCap":1870731109},{"date":"2026-03-06","current":-5.592845,"twenty":-12.7039,"median":-6.802294,"eighty":-5.77076,"marketCap":1828786465},{"date":"2026-03-13","current":-5.252211,"twenty":-12.674344,"median":-6.763399,"eighty":-5.752368,"marketCap":1719730391},{"date":"2026-03-19","current":-5.043522,"twenty":-12.646004,"median":-6.640729,"eighty":-5.717572,"marketCap":1652618961}],"updateTime":1774014301408},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02592\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620420690","title":"港股異動 | 撥康視雲-B(02592)跌超6%創新低 宣佈撤回CBT-009新藥臨床試驗申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2620420690","media":"智通财经","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620420690?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 10:35","pubTimestamp":1773974109,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，拨康视云-B跌超6%，低见1.82港元刷新上市以来新低。在提交新药临床试验申请后，药审中心批准了一款可比药品在中国上市。经后续与药审中心沟通后，公司相信由于各区域监管要求不同，将中国纳入多地区临床试验可能存在困难。为避免后续研发风险，及更好地分配集团的资源，公司已决定主动就可能于中国进行的第三期试验撤回现有的新药临床试验申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4090","CBT","02592","BK4588","BK1161","VXUS"],"gpt_icon":0},{"id":"2620244220","title":"撥康視雲-B(02592)：撤回CBT-009新藥臨床試驗申請 重新評估臨床開發策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2620244220","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620244220?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 19:05","pubTimestamp":1773918320,"startTime":"0","endTime":"0","summary":"在提交新药临床试验申请后，药审中心批准了一款可比药品在中国上市。经后续与药审中心沟通后，公司相信由于各区域监管要求不同，将中国纳入多地区临床试验可能存在困难。为避免后续研发风险，及更好地分配集团的资源，公司已决定主动就可能于中国进行的第三期试验撤回现有的新药临床试验申请。待完成相关补充研究或调整临床试验方案后，公司将根据情况再次与药审中心进行临床试验申请前咨询会议或重新提交临床试验申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4090","BK1161","02592","CBT"],"gpt_icon":0},{"id":"2620291559","title":"撥康視雲-B(02592)股東將股票存入建設亞洲 存倉市值1.94億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620291559","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620291559?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 08:09","pubTimestamp":1773878951,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，3月18日，拨康视云-B(02592)股东将股票存入建设亚洲，存仓市值1.94亿港元，占比11.23%。2月16日，拨康视云发布公告，公司于美利坚合众国(美国)特拉华州注册成立的全资附属公司 ADS Therapeutics LLC (ADS USA)，已完成有关于2025年12月12日向美国食品及药物管理局(美国药管局)提交的CBT-199(一种由本集团开发的潜在同类最佳眼科候选药物)新药临床试验申请(新药临床试验申请)的审查期。由于美国药管局未发出任何临床试验暂停令，新药临床试验申请现已生效，临床试验被认定为可安全推进。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2618613540","title":"每日沽空追蹤 | 撥康視雲-B 03月12日沽空量成交6500股，沽空比例為1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618613540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618613540?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 16:30","pubTimestamp":1773304233,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间03月12日，跌3.72%，卖空量成交6500股，较上一交易日增加225%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163443a463751d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163443a463751d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2618892060","title":"撥康視雲-B盤中異動 下午盤大幅下挫5.26%報2.160港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618892060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618892060?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 13:56","pubTimestamp":1773208581,"startTime":"0","endTime":"0","summary":"2026年03月11日下午盘13时56分，拨康视云-B股票出现波动，股价大幅下挫5.26%。截至发稿，该股报2.160港元/股，成交量9.75万股，换手率0.01%，振幅4.39%。资金方面，该股资金流入1.336万港元，流出20.149万港元。拨康视云-B股票所在的生物技术行业中，整体跌幅为1.97%。其相关个股中，中慧生物-B、迈博药业-B、翰思艾泰-B涨幅较大，振幅较大的相关个股有迈博药业-B、中慧生物-B、映恩生物-B，振幅分别为25.58%、20.00%、11.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311135621a460538a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311135621a460538a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2618676352","title":"撥康視雲-B盤中異動 大幅下跌6.88%報2.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618676352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618676352?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 09:40","pubTimestamp":1773020430,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时40分，拨康视云-B股票出现异动，股价急速下跌6.88%。截至发稿，该股报2.030港元/股，成交量500股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1015港元。拨康视云-B股票所在的生物技术行业中，整体跌幅为3.19%。其相关个股中，科济药业-B、维立志博-B、愉悦集团涨幅较大，振幅较大的相关个股有科济药业-B、派格生物医药-B、维立志博-B，振幅分别为30.36%、15.64%、12.63%。该公司拥有两款核心产品 CBT-001和CBT-009,均为自主研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909403097aa9b2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909403097aa9b2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2616326302","title":"撥康視雲-B盤中異動 早盤大幅跳水5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616326302?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 10:16","pubTimestamp":1772504216,"startTime":"0","endTime":"0","summary":"2026年03月03日早盘10时16分，拨康视云-B股票出现波动，股价急速下挫5.88%。截至发稿，该股报1.920港元/股，成交量12.15万股，换手率0.01%，振幅6.37%。拨康视云-B股票所在的生物技术行业中，整体跌幅为2.22%。其相关个股中，科笛-B、华领医药-B、轩竹生物-B涨幅较大，振幅较大的相关个股有旺山旺水-B、和誉-B、银诺医药-B，振幅分别为17.31%、10.77%、8.32%。拨康视云-B公司简介：Cloudbreak Pharma Inc是一家临床阶段的眼科生物技术公司,从事开发各种治疗方法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303101656a444561d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303101656a444561d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2616935147","title":"每日沽空追蹤 | 撥康視雲-B 03月02日沽空量成交2.1萬股，沽空比例為2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616935147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616935147?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 16:30","pubTimestamp":1772440235,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间03月02日，跌8.52%，卖空量成交2.1万股，较上一交易日增加75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163509a4415196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163509a4415196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"1131140470","title":"Cloudbreak Pharma（02592）2026年2月無新增發行或股份變動","url":"https://stock-news.laohu8.com/highlight/detail?id=1131140470","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131140470?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 15:01","pubTimestamp":1772434918,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc.于2026年3月2日发布截至2026年2月28日的证券变动月报。报告显示，本月公司已发行股本及库藏股数量均未发生增减。截至2月28日，已发行股份数为850,122,081股，库藏股份为0股，均与上月底保持一致，期间未有新增发行或购回注销活动。本月内，各相关计划项下均无新股发行、期权行使或库藏股转让行为，潜在可发行或转让股份数量保持不变。公告由公司秘书冯雅芳签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"gpt_icon":0},{"id":"2616230351","title":"撥康視雲-B盤中異動 股價大跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616230351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616230351?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 10:14","pubTimestamp":1772417685,"startTime":"0","endTime":"0","summary":"2026年03月02日早盘10时14分，拨康视云-B股票出现异动，股价快速下跌5.83%。截至发稿，该股报2.100港元/股，成交量15.15万股，换手率0.02%，振幅5.83%。资金方面，该股资金流入8.1195万港元，流出23.631万港元。拨康视云-B股票所在的生物技术行业中，整体跌幅为2.97%。拨康视云-B公司简介：Cloudbreak Pharma Inc是一家临床阶段的眼科生物技术公司,从事开发各种治疗方法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302101445a72f6a02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302101445a72f6a02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2614931864","title":"每日沽空追蹤 | 撥康視雲-B 02月27日沽空量成交1000股，沽空比例為0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614931864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614931864?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 16:30","pubTimestamp":1772181033,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月27日，跌1.33%，卖空量成交1000股，较上一交易日减少98.45%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163439a725f46e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163439a725f46e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2614078953","title":"每日沽空追蹤 | 撥康視雲-B 02月26日沽空量成交2.05萬股，沽空比例為7.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614078953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614078953?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 16:30","pubTimestamp":1772094632,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月26日，涨0.44%，卖空量成交2.05万股，较上一交易日减少41.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163445a7219b90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163445a7219b90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2614572721","title":"每日沽空追蹤 | 撥康視雲-B 02月24日沽空量成交1.65萬股，沽空比例為7.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614572721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614572721?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 16:30","pubTimestamp":1771921831,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月24日，跌0.43%，卖空量成交1.65万股，较上一交易日减少54.79%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163500a4c23657&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163500a4c23657&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2611107947","title":"每日沽空追蹤 | 撥康視雲-B 02月16日沽空量成交1.45萬股，沽空比例為15.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611107947","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611107947?lang=zh_tw&edition=fundamental","pubTime":"2026-02-16 16:30","pubTimestamp":1771230628,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月16日，涨0.44%，卖空量成交1.45万股，较上一交易日减少77.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163352a4a9f7cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163352a4a9f7cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2611615103","title":"撥康視雲-B(02592)：CBT-199新藥臨床試驗申請已生效，臨床試驗被認定為可安全推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2611615103","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611615103?lang=zh_tw&edition=fundamental","pubTime":"2026-02-16 12:45","pubTimestamp":1771217106,"startTime":"0","endTime":"0","summary":"由于美国药管局未发出任何临床试验暂停令，新药临床试验申请现已生效，临床试验被认定为可安全推进。CBT-199已自2023年6月起于临床前动物研究中进行安全性和耐受性评估，有关研究预期将有助于未来的临床试验。本公司认为，由于CBT-199的临床试验现被认为可安全推进，标志着CBT-199临床开发的关键里程碑，且本集团已正式获授权启动第2阶段临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CBT","BK4090","BK1161","02592"],"gpt_icon":0},{"id":"2611904294","title":"每日沽空追蹤 | 撥康視雲-B 02月12日沽空量成交1.35萬股，沽空比例為2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611904294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611904294?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 16:30","pubTimestamp":1770885032,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月12日，跌4.2%，卖空量成交1.35万股，较上一交易日减少56.45%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163438a49ba024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163438a49ba024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2610388910","title":"撥康視雲-B盤中異動 臨近收盤大幅下挫5.04%報2.260港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610388910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610388910?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 15:37","pubTimestamp":1770881829,"startTime":"0","endTime":"0","summary":"2026年02月12日临近收盘15时37分，拨康视云-B股票出现波动，股价大幅跳水5.04%。截至发稿，该股报2.260港元/股，成交量50.6万股，换手率0.06%，振幅3.36%。资金方面，该股资金流入33.798万港元，流出73.5675万港元。拨康视云-B股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，翰思艾泰-B、瑞博生物-B、方达控股涨幅较大，振幅较大的相关个股有翰思艾泰-B、瑞博生物-B、百奥赛图-B，振幅分别为21.53%、13.93%、12.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602121537099540dd60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602121537099540dd60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2610162568","title":"每日沽空追蹤 | 撥康視雲-B 02月10日沽空量成交2.1萬股，沽空比例為11.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610162568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610162568?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 16:30","pubTimestamp":1770712234,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月10日，涨2.19%，卖空量成交2.1万股，较上一交易日增加55.56%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163441a6e9ae2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163441a6e9ae2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2610075652","title":"每日沽空追蹤 | 撥康視雲-B 02月09日沽空量成交9500股，沽空比例為1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610075652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610075652?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 16:30","pubTimestamp":1770625832,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月09日，涨0.88%，卖空量成交9500股，较上一交易日减少92.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163902a48e5d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163902a48e5d68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2609599255","title":"每日沽空追蹤 | 撥康視雲-B 02月06日沽空量成交2.9萬股，沽空比例為3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609599255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609599255?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 16:30","pubTimestamp":1770366634,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间02月06日，跌6.61%，卖空量成交2.9万股，较上一交易日减少29.27%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163529a483cff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163529a483cff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":115,"code":"91000000","status":"200"}]}}